AI Technology IDs Genetic Diseases by Analyzing Facial Photos

TUESDAY, Jan. 8, 2019 — Certain genetic diseases can be detected by new artificial intelligence technology that analyzes a photo of a person’s face, according to a study published online Jan. 7 in Nature Medicine. The DeepGestalt technology was better than doctors at identifying a range of genetic syndromes, CNN reported. Examples of conditions that can be identified by the […]

Read more

Lynparza (olaparib) Approved by US FDA for First-Line Maintenance Therapy in BRCA-Mutated Advanced Ovarian Cancer

19 December 2018 — AstraZeneca and Merck & Co., Inc., (Merck: known as MSD outside the US and Canada) today announced that the US Food and Drug Administration (FDA) has approved Lynparza for use as maintenance treatment of adult patients with deleterious or suspected deleterious germline or somatic BRCA-mutated (gBRCAm or sBRCAm) advanced epithelial ovarian, fallopian tube or primary peritoneal […]

Read more

Impact of opioid epidemic on children varies by state

A new report released by the Drug Enforcement Administration finds most overdose deaths are caused by prescription drugs, including opioids. While opioid abuse continues to plague certain states more than others, each state is unique in how it attempts to stem the crisis and its effect on families. These differences have resulted in significant variation across the country between opioid […]

Read more

Removal of the Appendix reduces the risk of Parkinson’s disease by 20%

According to new research, after the removal of the Appendix, almost 20% reduced chance of developing Parkinson’s disease. To such conclusion scientists have come, having analysed the data of 1.6 million. The results of their study were published in the journal Science Translational Medicine. Parkinson’s disease is a common disorder. And therefore, most likely, she may have a few points […]

Read more